Meet our members: Zhandos Amankulov

We speak to Zhandos Amankulov, Head of the Department of Radiology and Nuclear Medicine at Kazakh Institute of Oncology and Radiology, Kazakhstan

What led you to work in the field of lung cancer?

I am leading the implementation of lung cancer screening in Kazakhstan, focusing on early detection to improve patient outcomes. My work involves developing national screening strategies, integrating advanced imaging techniques like low-dose computed tomography (LDCT), and expanding access to diagnostic services. By enhancing early diagnosis in Kazakhstan, I aim to reduce the number of deaths caused by lung cancer and improve overall cancer care.

What does an average work day look like for you?

My day typically involves reviewing imaging studies, consulting with colleagues on complex cases and overseeing research projects. I also work on developing protocols for lung cancer screening, as well as mentoring students and managing departmental operations. Discussions on expanding positron emission tomography/computed tomography (PET/CT) services, strategic planning for national screening programmes, and meetings are key parts of my routine.

What is working well in Kazakhstan, and what could be improved?

Kazakhstan has made progress in lung cancer diagnosis and treatment, with access to modern imaging and therapies. However, screening has yet to be fully implemented across the whole country.

A cost-effectiveness study is the next step needed, as it is essential to demonstrating the benefits of screening and thus obtaining support from the Ministry of Health. In turn, this support is key to ensuring lung cancer is detected earlier, and to improving outcomes for people living with the disease in Kazakhstan.

What motivated you to join the Lung Cancer Policy Network?

I joined the Lung Cancer Policy Network to collaborate with global experts and advocate for effective screening policies for lung cancer in Kazakhstan. Access to international research, best practices and policy discussions helps strengthen our national screening programme. And sharing experiences and learning from others is crucial for improving early detection and outcomes.

What would you like to see from the Network as it develops?

I would like to see more research on cost-effectiveness, policy advocacy tools and case studies from successful screening programmes.

What changes would you like to see in lung cancer care on a global level?

I want to see the widespread implementation of screening programmes, increased access to advanced diagnostics and improved treatment equity globally. Stronger policy support, cost-effective screening strategies and expanded early detection efforts – especially in low-resource settings – are essential to reducing lung cancer mortality and improving  outcomes worldwide.

What recent research have you found the most interesting or exciting?

One of the most exciting breakthroughs in lung cancer research is the advancement of AI in imaging for early detection. AI-powered tools enhance nodule detection and risk assessment, improving screening accuracy. Additionally, advancements in targeted therapies and immunotherapy, particularly for early-stage lung cancer, have significantly increased survival rates.

Outside of work, what do you spend your time doing?

Outside of work, I spend time with family, stay updated on medical advancements, and engage in outdoor activities. I am also actively working to establish new PET/CT centres in Kazakhstan to expand access to advanced imaging. Additionally, I enjoy travelling and exchanging ideas on research and healthcare policies with colleagues around the world.

The Lung Cancer Policy Network brings together a unique mix of experts in lung cancer from around the world, united in their passion to eliminate lung cancer as a cause of death.

We regularly share profiles of our members so that you can find out more about what led them to work in lung cancer and what changes they would like to see in lung cancer prevention and care on a global level.